SB01
Head and Neck Cancer
Phase 2Active
Key Facts
About SynCore Biotechnology
Taiwan‑based public biotech advancing oncology, ophthalmology and dermatology pipelines with Phase‑3 assets.
View full company profileTherapeutic Areas
Other Head and Neck Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Setanaxib | Calliditas Therapeutics | Phase 2 |
| BMX-001 | BioMimetix JV | Phase 2 |
| Undisclosed Antibody/ADC Program | Frezent Biological Solutions | Pre-clinical |